Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 22% ± 5% | |
microglial cell | 8 studies | 25% ± 9% | |
myeloid cell | 6 studies | 20% ± 5% | |
macrophage | 6 studies | 25% ± 10% | |
epithelial cell | 5 studies | 37% ± 18% | |
ciliated cell | 4 studies | 27% ± 8% | |
astrocyte | 4 studies | 25% ± 7% | |
glutamatergic neuron | 4 studies | 42% ± 19% | |
GABAergic neuron | 3 studies | 42% ± 11% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 6% | |
dendritic cell | 3 studies | 26% ± 9% | |
basal cell | 3 studies | 32% ± 21% | |
neuron | 3 studies | 25% ± 7% | |
oligodendrocyte | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3475.96 | 459 / 459 | 100% | 63.93 | 1118 / 1118 |
esophagus | 100% | 2862.90 | 1445 / 1445 | 100% | 58.51 | 183 / 183 |
ovary | 100% | 2822.88 | 180 / 180 | 100% | 45.03 | 430 / 430 |
brain | 100% | 4784.81 | 2641 / 2642 | 100% | 87.64 | 705 / 705 |
intestine | 100% | 3495.00 | 966 / 966 | 100% | 53.37 | 526 / 527 |
bladder | 100% | 3431.81 | 21 / 21 | 100% | 46.03 | 503 / 504 |
prostate | 100% | 3138.79 | 245 / 245 | 100% | 52.78 | 501 / 502 |
uterus | 100% | 2996.42 | 170 / 170 | 100% | 49.86 | 458 / 459 |
stomach | 100% | 2097.65 | 358 / 359 | 100% | 51.46 | 286 / 286 |
thymus | 100% | 3583.34 | 652 / 653 | 100% | 66.83 | 603 / 605 |
kidney | 100% | 2996.00 | 89 / 89 | 99% | 49.04 | 896 / 901 |
lung | 99% | 3253.79 | 575 / 578 | 100% | 52.27 | 1154 / 1155 |
skin | 100% | 3680.78 | 1801 / 1809 | 97% | 68.64 | 460 / 472 |
adrenal gland | 100% | 2899.00 | 258 / 258 | 95% | 44.60 | 219 / 230 |
liver | 98% | 1688.87 | 222 / 226 | 96% | 24.89 | 391 / 406 |
pancreas | 85% | 1184.72 | 280 / 328 | 99% | 48.37 | 176 / 178 |
adipose | 100% | 3878.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 58.28 | 29 / 29 |
muscle | 100% | 19346.04 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2758.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.76 | 1 / 1 |
blood vessel | 100% | 3149.76 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 6284.88 | 834 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 30.00 | 72 / 80 |
peripheral blood | 63% | 1998.14 | 585 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0022008 | Biological process | neurogenesis |
GO_0043393 | Biological process | regulation of protein binding |
GO_0007517 | Biological process | muscle organ development |
GO_0000932 | Cellular component | P-body |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0042802 | Molecular function | identical protein binding |
GO_0097602 | Molecular function | cullin family protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BTBD1 |
Protein name | BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8) (HCV NS5A-transactivated protein 8) BTB domain containing 1 |
Synonyms | NS5ATP8 C15orf1 |
Description | FUNCTION: Probable substrate-specific adapter of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins . Seems to regulate expression levels and/or subnuclear distribution of TOP1, via an unknown mechanism (By similarity). May play a role in mesenchymal differentiation where it promotes myogenic differentiation and suppresses adipogenesis (By similarity). . |
Accessions | Q9H0C5 ENST00000559652.5 H0YL89 ENST00000261721.9 [Q9H0C5-1] Q3ZTS5 ENST00000379403.2 [Q9H0C5-2] |